MMSI Merit Medical Systems Inc.

Merit Medical Launches One-Vac™ Evacuated Drainage Bottle for Percutaneous Fluid Collection and Discard

Merit Medical Launches One-Vac™ Evacuated Drainage Bottle for Percutaneous Fluid Collection and Discard

Advanced design makes sample collection simple, efficient, and safe

SOUTH JORDAN, Utah, Aug. 16, 2021 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy, today announced the commercial launch of the One-Vac™ Evacuated Drainage Bottle (One-Vac) for use to aspirate, remove, or sample body fluids.

The One-Vac is ideal for thoracentesis and paracentesis procedures and patients with diseases that require fluid drainage as part of their care plan. The One-Vac features an advanced design that makes collection and discard simple, efficient, and safe. An ergonomic handle allows you to start, stop, and regulate flow with ease. The handle is also easy to remove, minimizing spills during discard. The bottleneck is easy to hold, and the entire device is made of durable plastic designed to prevent breakage.

“We designed the One-Vac Evacuated Drainage Bottle to provide a smarter option for aspirating, removing, or sampling percutaneous fluids,” said Fred P. Lampropoulos, Merit Medical’s Chairman and CEO. “The product’s launch represents an important milestone for our expanding drainage portfolio, which we’ve developed by applying physician feedback, investing in new technologies, and improving upon legacy products. Early adopters have praised the device’s intuitive ease of use, resealing capability, and start-and-stop activation method. We are grateful for the customer feedback provided to date and look forward to bringing more innovative new technologies to market soon.”

ABOUT MERIT MEDICAL

Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture, and distribution of proprietary disposable medical devices used in interventional, diagnostic, and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care, and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling in excess of 500 individuals. Merit employs approximately 6,300 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Rockland, Massachusetts; Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.

TRADEMARKS

Unless noted otherwise, trademarks and registered trademarks used in this release are the property of Merit Medical Systems, Inc. and its subsidiaries in the United States and other jurisdictions.

CONTACTS

PR/Media Inquiries

Teresa Johnson

Merit Medical

|

Investor Inquiries

Mike Piccinino, CFA, IRC

Westwicke - ICR

|



EN
16/08/2021

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Merit Medical Systems Inc.

 PRESS RELEASE

Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Ac...

Merit Medical Signs Asset Purchase Agreement with PENTAX Medical to Acquire C2 CryoBalloon Technology Asset acquisition would expand Merit’s Endoscopy portfolio with an innovative device to treat patients suffering from Barretts esophagus and other gastrointestinal disorders. Asset acquisition is projected to add approximately $6 million to $8 million of revenue in 2026 in a key gastroenterology market that leverages Merit’s existing commercial footprint.   SOUTH JORDAN, Utah, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare tech...

 PRESS RELEASE

Merit Medical Systems to Announce Third Quarter 2025 Results on Octobe...

Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025 SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2025, after the close of the stock market on Thursday, October 30, 2025. Merit plans to hold its investor conference call on the same day (Thursday, October 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). ...

 PRESS RELEASE

Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with...

Merit Medical Announces SCOUT Milestone: 750,000 Patients Treated with Wire-Free Technology SCOUT Radar Localization use grows, supporting more successful surgeries and improved patient care SOUTH JORDAN, Utah, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced a significant milestone for breast cancer treatment: SCOUT® Radar Localization use has reached 750,000 patients worldwide.1 This global achievement coincides with Breast Cancer Awareness Month, a time dedicated to educating the public about the ...

 PRESS RELEASE

Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Ar...

Merit Medical Embosphere Microspheres Achieve CE Mark for Genicular Artery Embolisation to Treat Knee Osteoarthritis Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere’s consistent, predictable, and effective clinical results. SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced that Embosphere® Microspheres are now indicated in the European Union for use in genicular artery embolisation (GAE) to treat patients with knee osteoarthritis (OA). The...

 PRESS RELEASE

First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North Americ...

First Patient Enrolled in Merit Medical’s WRAPSODY (WRAP) North America Registry The WRAP North America registry is a prospective, multicenter study designed to collect real-world safety and effectiveness data on the WRAPSODY® Cell-Impermeable Endoprosthesis (CIE).The first WRAP North America patient was enrolled at Bluff City Vascular, an interventional nephrology and vascular access center in Memphis, TN. SOUTH JORDAN, Utah, Aug. 18, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, announced today the successful enroll...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch